Problems In Drug DevelopmentThe trillion dollar pharmaceutical industry is in peril where current drug development pipeline is slow and inefficient and incapable of being extended to multi-combination drug therapies. It takes too long (12-16 years), costs too much ($5 billion per drug), and only 20% entering Phase 1 clinical trials are successful. The current drug development process is archaic, wet lab centric, relying on in vitro and in vivo, in both animals and humans, and not information centric, and unable to integrate and reuse existing scientific data and knowledge.
The CytoSolve® SolutionBased on proprietary in silico technology and a feedback systems design that reuses scientific data from wet lab and clinical trials, CytoSolve offers a revolutionary and proven information-centric platform that enables accurate quantitative mechanistic models, for predicting complex molecular phenomena, for the rapid testing and development of single and multi-combination compounds for drug, nutritional supplement, and medical foods, by minimizing the need for in vitro and in vivo testing.
Integrating Published Scientific Research from Global Institutions
Papers and Citations
Information about development of CytoSolve™ has evinced keen interest among the research community world-wide. A number of papers has been written on the CytoSolve™ platform and itsRead more